Clin2
NCT07166874Possibly a fitRecruiting

Gluten-free diet for ankylosing spondylitis

Ankylosing Spondylitis

Part of Bones, joints & muscles clinical trials.

This study looks at how a gluten-free diet affects people with ankylosing spondylitis (a type of arthritis that mainly affects the spine). You would eat no gluten (found in wheat, barley, and rye) for a period of time to see if it helps reduce symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You have been diagnosed with axial spondyloarthritis (a type of inflammatory arthritis of the spine) by a rheumatologist
  • You are between 18 and 64 years old
  • You have been on a stable dose of your current medications (NSAIDs or DMARDs) for at least 3 months
  • You do not have celiac disease, ulcerative colitis, Crohn's disease, irritable bowel syndrome, type 1 or type 2 diabetes, or Hashimoto's thyroiditis
  • You are not pregnant or breastfeeding, and have not taken omega-3 supplements or vitamins A, C, or E regularly in the last 3 months
  • Your body mass index (BMI) is between 18.5 and 30 (calculate your BMI using height and weight)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07396194Not yet recruiting
Study of ankylosing spondylitis treatment options

This study looks at treatments for people with ankylosing spondylitis, a type of arthritis that affects the spine. It aims to find better ways to manage symptoms and improve quality of life.

NCT07632599Not yet recruiting· Phase 1
Stem cell treatment for active ankylosing spondylitis

This trial tests whether a single infusion of stem cells from a healthy donor's bone marrow can help reduce inflammation and pain in people with active ankylosing spondylitis. If you are young and have not been helped by standard treatments, this study might offer a new option.

Shenzhen, Guangdong
NCT07261644Recruiting· Phase 3
Study of a new drug for active ankylosing spondylitis

This study tests a new medication (called 608) for adults with active ankylosing spondylitis (AS). It aims to see if the drug can reduce AS symptoms and improve quality of life.

Beijing, Beijing Municipality
NCT05962762Not yet recruiting· Phase 1
Umbilical cord stem cells for ankylosing spondylitis

This trial tests whether a single infusion of stem cells from donated umbilical cord tissue is safe and well-tolerated in people with active ankylosing spondylitis (AS). It may reduce inflammation and help control symptoms when standard treatments are not working well enough.

NCT06076083Recruiting
Microbiome study in Korean patients with ankylosing spondylitis

This study looks at the bacteria living in your body (the microbiome) in people with ankylosing spondylitis and their close family members. Researchers hope to better understand how these bacteria relate to the disease, which may lead to better treatments in the future.

Seoul, Kyungheedae-ro 23
NCT06339957Recruiting
Rheumatology diet study for arthritis and related conditions

This study looks at how diet affects people with different types of arthritis and related autoimmune conditions. If you are a UCF Health patient between 18 and 65, you may be able to help researchers learn more about which foods help or worsen symptoms.

Orlando, Florida

Hear when a new Ankylosing Spondylitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.